Author: digi

Run Logs & Reproducibility: Scripted Builds, Env Hashes, Params

Posted on digi By digi

Run Logs & Reproducibility: Scripted Builds, Env Hashes, Params Run Logs and Reproducibility That Hold Up: Scripted Builds, Environment Hashes, and Parameter Files Done Right Outcome-aligned reproducibility: why scripted builds and evidence-grade run logs matter in US/UK/EU reviews Define “reproducible” the way inspectors do To a regulator, reproducibility isn’t an academic virtue—it’s operational proof that…

Read More “Run Logs & Reproducibility: Scripted Builds, Env Hashes, Params” »

Biostats, CDISC & Traceability, Clinical Trial Operations & Data Integrity

CTMS ↔ eTMF Data Mapping Guide: Fields, Ownership, Audit Trails

Posted on digi By digi

CTMS ↔ eTMF Data Mapping Guide: Fields, Ownership, Audit Trails CTMS ↔ eTMF Data Mapping: Field-Level Rules, Ownership, and Audit Trails That Stand Up in FDA/MHRA Inspections Why precise CTMS–eTMF mapping wins inspections: from “two versions of truth” to one stitched record Define the outcome: one story told by two systems The purpose of a…

Read More “CTMS ↔ eTMF Data Mapping Guide: Fields, Ownership, Audit Trails” »

Clinical Trial Operations & Data Integrity, TMF & eTMF

Estimands → Outputs Traceability: Keep the Thread Intact

Posted on digi By digi

Estimands → Outputs Traceability: Keep the Thread Intact Keeping the Estimands → Outputs Thread Intact: A Practical Traceability Playbook Why estimand-to-output traceability is the backbone of inspection readiness The “thread” reviewers try to pull When regulators open your submission, they will try to pull a single thread: “From the stated estimand, can I travel—quickly and…

Read More “Estimands → Outputs Traceability: Keep the Thread Intact” »

Biostats, CDISC & Traceability, Clinical Trial Operations & Data Integrity

Fix TMF Errors Fast: Misfiles, Missing Signatures, Late Docs

Posted on digi By digi

Fix TMF Errors Fast: Misfiles, Missing Signatures, Late Docs Rapid TMF Remediation: Fixing Misfiles, Missing Signatures, and Late Documents Before Inspectors Ask Why speed matters: converting TMF defects into inspection-ready evidence within days The three failure patterns that derail inspections Across programs, the fastest way to lose credibility is the same: misfiled artifacts that can’t…

Read More “Fix TMF Errors Fast: Misfiles, Missing Signatures, Late Docs” »

Clinical Trial Operations & Data Integrity, TMF & eTMF

MedDRA/WHODrug & Footnotes: Version Control That’s Traceable

Posted on digi By digi

MedDRA/WHODrug & Footnotes: Version Control That’s Traceable Make MedDRA/WHODrug Version Control Traceable: Footnotes, Change Logs, and Evidence That Survive Review Why dictionary version control is a regulatory deliverable (not just a data-management task) What “traceable” means for coded data When reviewers challenge an adverse event count or a concomitant medication pattern, they are really testing…

Read More “MedDRA/WHODrug & Footnotes: Version Control That’s Traceable” »

Biostats, CDISC & Traceability, Clinical Trial Operations & Data Integrity

TMF QC & Reconciliation SOP: Roles, Cadence, Checklists

Posted on digi By digi

TMF QC & Reconciliation SOP: Roles, Cadence, Checklists TMF QC and Reconciliation SOP: Defining Roles, Cadence, and Checklists that Pass Real Inspections Purpose and scope: a pragmatic SOP that proves control, not bureaucracy What “good” looks like for TMF QC and reconciliation A credible Trial Master File program is simple to explain and fast to…

Read More “TMF QC & Reconciliation SOP: Roles, Cadence, Checklists” »

Clinical Trial Operations & Data Integrity, TMF & eTMF

TMF Timeliness SLAs & Thresholds: Audit-Ready Evidence

Posted on digi By digi

TMF Timeliness SLAs & Thresholds: Audit-Ready Evidence TMF Timeliness SLAs & Thresholds: How to Produce Audit-Ready Evidence That Survives Live Inspection Why timeliness decides inspection outcomes—and how to make it measurable From “filed eventually” to “filed on time—and provably so” Regulators do not ask whether documents exist; they ask whether the Trial Master File (TMF)…

Read More “TMF Timeliness SLAs & Thresholds: Audit-Ready Evidence” »

Clinical Trial Operations & Data Integrity, TMF & eTMF

Listings QC Checklist: Filters, Columns, Logic — No Last-Minute Fixes

Posted on digi By digi

Listings QC Checklist: Filters, Columns, Logic — No Last-Minute Fixes Listings QC That Doesn’t Break on Submission Day: Filters, Columns, and Logic You Can Defend Why listings QC is a regulatory deliverable, not a formatting chore The purpose of listings (and why reviewers open them first) Clinical data listings are where reviewers go when a…

Read More “Listings QC Checklist: Filters, Columns, Logic — No Last-Minute Fixes” »

Biostats, CDISC & Traceability, Clinical Trial Operations & Data Integrity

Proven TMF KPIs for FDA/MHRA Inspection Readiness

Posted on digi By digi

Proven TMF KPIs for FDA/MHRA Inspection Readiness Proven TMF KPIs for FDA/MHRA Inspection Readiness: The Metrics, Methods, and Evidence That Survive Real Audits Why measurable TMF performance is the fastest path to inspection readiness Anchor your TMF to a small set of outcome-driven KPIs Inspectors don’t reward volume; they reward control. A Trial Master File…

Read More “Proven TMF KPIs for FDA/MHRA Inspection Readiness” »

Clinical Trial Operations & Data Integrity, TMF & eTMF

Double Programming vs Peer Review: Risk-Based Verification

Posted on digi By digi

Double Programming vs Peer Review: Risk-Based Verification Double Programming vs Peer Review: Choosing Risk-Based Verification that Survives Inspection Outcome-first verification: define the decision, then pick the method What success looks like for verification Verification is successful when a reviewer can select any number in any output, travel to the rule that produced it, and re-generate…

Read More “Double Programming vs Peer Review: Risk-Based Verification” »

Biostats, CDISC & Traceability, Clinical Trial Operations & Data Integrity